Dermira is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering important new treatments to the millions of patients living with chronic skin conditions.
We are committed to understanding the needs of both patients and physicians and using our insight to identify and develop leading-edge medical dermatology clinical programs.
02/16/18 4:00 p.m. ET
Minimum 15 minutes delay
- 02/17/18New Data in Pediatric Patients with Axillary Hyperhidrosis Presented During Late-Breaking Research Forum at the 76th Annual Meeting of the American Academy of Dermatology
- 02/12/18Dermira Showcases Commitment to Hyperhidrosis Education and Treatment at Leading Dermatology Conference
- 01/31/18Dermira Initiates Phase 2b Dose-Ranging Study Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis
There are currently no events scheduled.
|Data provided by Nasdaq. Minimum 15 minutes delayed.|